Gene Query: CDC16

Dataset Description Geneva Score
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 115.16
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 48.53
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 28.11
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 27.75
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 25.83
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 24.03
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 23.51
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 20.12
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 20.05
RNAseq Study in CC-671 Treated Cal-51 Cells 19.51
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 18.76
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 16.19
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 15.68
JunB control of keratinocyte-mediated inflammation [RNA-seq] 15.68
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 15.07
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 15.07
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 14.66
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 14.2
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 14.2
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 14.05
RNA-Seq from early time points in the kidney differentiation protocol 13.65
Cell responses to dysregulated VZV-induced cell-cell fusion 13.59
Gene expression changes caused by KRAS in MCF-10A 13.55
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 13.43
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 13.38
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 12.31
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 12.3
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 12.19
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 12.12
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 12.12
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 11.82
IL-33 activates tumor stroma to promote intestinal polyposis 11.43
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 10.97
Differentially expressed genes post knock down of lincDUSP26 10.75
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 10.47
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 10.41
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 10.41
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 10.3
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 10.18
Patient-derived luminal breast cancer xenografts with progestins 10.15
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 10.15
Gene expression changes associated with resistance to tagraxofusp (SL-401) 10.15
Transcriptomic analyssis following EHMT1/2 inhibition 10.1
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 10.02
Seletive inhibition of CDK9 in DLBCL cell lines 9.67
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 9.61
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 9.59
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 9.54
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 9.53
A role for ZNF598 in post-transcriptional gene regulation 9.44
Rorc disruption in human FG pancreatic cancer cells 9.43
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 9.4
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 9.38
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 9.08
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 9.03
Human embryonic stem cells in E8 and AKIT culture medium 9.03
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 9.01
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 9.01
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 8.95
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 8.95
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 8.85
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 8.66
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 8.66
LNCaP treated with iBET 8.64
RNA-seq analysis of BAP1-depleted uveal melanoma cells 8.61
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 8.59
K562 polyA RNA-Seq 8.57
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 8.39
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 8.34
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 8.25
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 8.25
Survival of pancreatic cancer cells lacking KRAS function 8.09
Control of prostate tumour growth by the long non-coding RNA GHSROS 7.88
Transcriptomic profiling of human peripheral blood-derived mast cells 7.86
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 7.86
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 7.81
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 7.73
Gene expression changes in human melanoma cell lines compared to primary melanocytes 7.67
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 7.66
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 7.6
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 7.58
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 7.5
hTERT promotes cell adhesion and migration independent of telomerase activity 7.42
RNA-seq analysis to identify the genes regulated by p53-SET interplay 7.39
Epigenetic reprogramming of melanoma cells by vitamin C treatment 7.38
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 7.37
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 7.32
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 7.29
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 7.29
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 7.29
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 7.21
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 7.16
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 7.13
HEK293 TFAM Knockout Expression Study 6.97
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 6.96
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 6.96
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 6.92
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 6.78
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 6.77
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 6.74
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 6.65
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 6.56
Identifying the molecular mode of action of itraconazole in colorectal cancer 6.56
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 6.48
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 6.48
An integrative analysis of non-coding regulatory DNA variations associated with autism 6.45
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 6.44
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 6.42
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 6.4
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 6.4
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 6.4
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 6.4
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 6.37
Global response to chemotherapy-induced apoptosis 6.34
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 6.34
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 6.33
Accurate annotation of human protein-coding small open reading frames 6.27
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 6.24
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 6.24
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 6.22
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 6.15
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 6.15
SLIGRL-induced gene expression changes in NHEK cells 6.11
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 6.09
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 6.06
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 6.02
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 6.0
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 5.98
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 5.98
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 5.97
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 5.97
Proteomics identifies a marker signature of MAPKi resistance in melanoma 5.97
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 5.94
SUV420H2 knockdown in PANC-1 5.92
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 5.85
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 5.74
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 5.72
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 5.66
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 5.6
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 5.6
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 5.6
Transcriptomic analysis of LSD1 5.58
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 5.52
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 5.5
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 5.47
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 5.46
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 5.45
Identification of a LIF-responsive replication-competent human β cell 5.44
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 5.44
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 5.43
The transcriptome and chromatin accessbility landscape of mammalian germline 5.43
RNA-seq of YB5 cells treated with Proscillaridin A 5.42
Differential analysis of gene regulation at transcript resolution by RNA-Seq 5.4
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 5.4
Characterization of parental and rociletinib-resistant derived H1975 cell lines 5.38
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 5.38
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 5.37
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 5.37
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 5.36
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 5.33
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 5.33
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 5.31
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 5.28
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 5.24
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 5.23
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 5.22
Depicting early human development and germ cell origin with porcine embryos 5.18
The interplay between SOX4 and SMAD3 in the context of breast cancer 5.18
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 5.15
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 5.15
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 5.14
RNA sequencing of human mammary epithelial cells 5.13
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 5.13
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 5.13
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 5.13
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 5.12
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 5.12
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 5.07
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 5.06
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 5.03
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 5.03
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 5.03
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 5.02
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 5.01
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 4.97
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 4.97
The effect of PPARG inhibition on human angiomyolipoma cells 4.95
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 4.95
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 4.95
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 4.94
T47D RNA-seq and ChrRNA-seq data 4.94
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 4.94
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 4.93
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 4.93
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 4.88
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 4.83
RNA sequencing of BT142 and TS603 cell lines 4.83
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 4.83
Gene expression profile of multiple myeloma cell lines treated with CB-5083 4.8
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 4.78
In vivo genome editing restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers 4.73
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 4.71
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 4.71
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 4.68
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 4.67
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 4.67
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 4.66
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 4.65
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 4.65
A sister of NANOG regulates genes expressed in pre-implantation human development 4.64
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 4.61
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 4.6
RNA-seq analysis of AML cells in response to ASLAN003 4.6
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 4.58
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 4.56
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 4.55
4sU-seq of HFF exposed to salt and heat stress 4.54
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 4.51
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 4.45
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 4.38
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 4.38
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 4.38
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 4.37
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 4.35
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 4.34
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 4.33
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 4.33
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 4.32
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 4.3
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 4.28
Differetially expressed genes after hTR overexpression in U2OS cells 4.27
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 4.26
Iron response of HepG2 cells 4.26
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 4.24
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 4.18
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 4.17
Gene expression in GBM with Cav3.2 inhibition 4.16
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 4.15
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 4.14
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 4.1
Expression profiling of etoposide-induced senescent cells 4.1
Effect of nuclear IL-33 on gene expression 4.06
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 4.05
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 4.05
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 4.05
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 4.03
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 4.01
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 4.0
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.98
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 3.98
RNA m5C Methylation in breast cancer using MeRIP-Seq 3.97
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 3.97
RNA-seq analysis of RALD iPSCs after in vitro differentiation 3.96
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 3.96
Dysregulated immune system networks in war veterans with PTSD 3.96
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 3.91
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 3.9
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 3.9
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 3.89
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 3.86
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 3.85
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 3.85
KLF6-dependent transcription in renal cancer cells 3.8
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 3.77
naive T cell heterogeneity after neonatal thymectomy 3.75
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 3.73
An acquired vulnerability of drug resistant melanoma with therapeutic potential 3.72
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 3.72
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 3.68
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 3.67
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 3.64
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 3.61
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 3.54
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 3.53
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 3.51
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 3.46
Next Generation Sequencing of human SMA and healthy control Motor Neurons 3.45
CD86 regulates a pro-survival signal in myeloma cells 3.44
Molecular Criteria for Defining the Naive Human Pluripotent State 3.44
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 3.4
Patient-derived xenograft platform for metastatic melanoma 3.38
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 3.37
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 3.37
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 3.3
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 3.3
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 3.3
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 3.27
X-Ray induced DNA-Hydroxymethylation changes 3.2
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 3.17
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 3.17
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 3.15
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 3.11
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 3.1
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 3.09
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 3.09
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 3.07
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 3.05
CDK4/6 inhibitor resistance in prostate cancer 3.03
Biological effect of chronic mistranslation in mammalian cells 3.03
A transcriptome dataset revealing the molecular features of breast cancer stem cells 3.01
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 2.97
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 2.88
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 2.86
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 2.86
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 2.83
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 2.81
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 2.78
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 2.76
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 2.72
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 2.71
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 2.68
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 2.68
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 2.66
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 2.66
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 2.64
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 2.62
RNA sequencing of T-ALL (COG study) 2.62
Analyses of T-ALL (COG study) 2.62
Total RNA-Seq data from leukemic patients with complex structural variants 2.62
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 2.59
Activity-dependent transcriptional changes in human neurons 2.55
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 2.54
quanTIseq: quantifying immune contexture of human tumors 2.51
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 2.5
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 2.5
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 2.49
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 2.47
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 2.47
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 2.45
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 2.41
RNA-seq of naive and primed ES cells 2.39
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 2.39
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 2.38
Redifferentiation of expanded human islet β cells by inhibition of ARX 2.38
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 2.35
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 2.34
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 2.22
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 2.21
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 2.21
An optimization system for isolating and sequencing of single human colon cancer cells 2.21
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 2.2
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 2.14
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 2.12
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 2.1
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 2.07
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 2.01
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 2.0
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 1.99
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 1.96
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 1.95
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 1.92
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 1.91
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 1.89
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 1.89
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 1.88
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 1.87
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 1.87
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 1.86
Discovering human diabetes-risk gene function with genetics and physiological assays 1.86
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 1.84
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.84
LIN28A Over-expression RNAseq 1.84
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 1.84
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 1.83
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.77
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 1.75
Effect of PRDM11 depletion in U2932 cells 1.74
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 1.72
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 1.72
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 1.69
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 1.69
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 1.68
Ribosomal protein RPL26 is the principal target of UFMylation 1.68
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 1.67
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 1.67
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 1.65
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 1.64
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 1.64
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 1.64
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 1.63
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 1.63
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 1.62
CDK12 mediated transcriptional regulation in U2OS cells 1.6
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.59
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 1.59
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 1.57
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 1.56
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 1.56
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 1.53
Primate-specific gene TMEM14B promotes cortical expansion and folding 1.53
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 1.53
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 1.52
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 1.52
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 1.51
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 1.5
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.47
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 1.46
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 1.44
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 1.42
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 1.37
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 1.37
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 1.37
Characterization of human ILC2 subsets 1.34
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 1.32
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 1.31
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 1.31
RNA-seq of MDA-MB-231 cells with TET1 knockout 1.3
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.29
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 1.26
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 1.26
Transcriptome profiling of A2M treated A549 Cell Line Samples 1.16
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 1.16
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 1.14
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 1.12
In situ CAPTURE of chromatin interactions by biotinylated dCas9 1.12
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 1.09
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 1.09
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 1.09
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 1.09
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 1.09
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 1.06
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 1.05
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 1.03
HBEC-shp53-PCHD7 0.99
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 0.96
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 0.96
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 0.93
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.92
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 0.89
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 0.89
Widespread regulated alternative splicing of single codons accelerates proteome evolution 0.85
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 0.83
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 0.83
The DNA methylation landscape of human melanoma 0.82
The DNA methylation landscape of human melanoma [RNA-Seq] 0.82
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 0.81
Hepatic transcriptome of pediatric hepatoblastoma. 0.72
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 0.7
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.67
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 0.67
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 0.66
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.64
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.64
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 0.6
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 0.6
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.54
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 0.52
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 0.52
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 0.52
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 0.51
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 0.5
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 0.5
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 0.5
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.5
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.48
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 0.48
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 0.47
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.44
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 0.42
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.42
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 0.42
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 0.41
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 0.4
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 0.4
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 0.38
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.37
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.37
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.35
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 0.32
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.32
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.32
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 0.3
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 0.28
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 0.27
SNHG5 siRNA knock down in HCT116 cells 0.27
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 0.25
Transcriptional landscape changes during human embryonic stem cell derivation 0.24
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.24
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.23
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 0.23
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 0.23
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 0.22
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 0.18
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 0.18
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 0.17
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.15
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 0.11
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 0.11
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.1
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.09
Myc activation coordinates gene transcription and protein translation responses 0.07
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.04
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.04
Downregulation of LATS kinases alters p53 to promote cell migration 0.04
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.04
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.04
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 0.02
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 0.02
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 0.01
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation